Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;32:331-337

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pagano, P. J.
Right arrow Articles by Clark, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pagano, P. J.
Right arrow Articles by Clark, J. K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

(Hypertension. 1998;32:331-337.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Angiotensin II Induces p67phox mRNA Expression and NADPH Oxidase Superoxide Generation in Rabbit Aortic Adventitial Fibroblasts

Patrick J. Pagano; Stephen J. Chanock; Deborah A. Siwik; Wilson S. Colucci; ; Justin K. Clark

From the Vascular Biology (P.J.P., J.K.C.) and Myocardial Biology (D.A.S., W.S.C.) Laboratories, Boston Medical Center, Boston, Mass; and the Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (S.J.C.).

Abstract—Superoxide radical (O2-) is ubiquitously critical to the bioactivity of endothelial nitric oxide. In angiotensin-dependent hypertension, vascular O2- levels rise and impede endothelium/nitric oxide–dependent vascular relaxation. We have reported that the major O2- source in the rabbit aorta is adventitial fibroblast phagocyte-like NADPH oxidase and shown that angiotensin (Ang) II treatment of adventitial fibroblasts causes a concentration-dependent increase in particulate NADPH-dependent O2-. From cultured rabbit aortic adventitial fibroblasts treated or not treated with Ang II, we prepared particulate fractions and measured lucigenin-enhanced chemiluminescence. Because [Sar1,Thr8]-Ang II, a generalized antagonist of Ang II and plausible inhibitor of the conversion of Ang II, reversed Ang II (10 nmol/L)–induced NADH- and NADPH-dependent O2- to basal levels, we tested the effect of the inhibitor of aminopeptidase N, amastatin (10 µmol/L), and found no effect on Ang II–stimulated O2-. Ang(1-7), Ang III, and Ang IV also were not effective in stimulating O2- levels at concentrations similar to those of Ang II. Kinetic analysis showed a rise in NADPH oxidase O2- production in response to Ang II, which peaks at 3 hours and returns to basal levels by 16 hours. p67phox, a cytosolic factor, appears to be affected at both the level of transcription and protein synthesis because actinomycin and cycloheximide individually inhibited the observed effect. A partial sequence of p67phox was recovered by reverse transcriptase from mRNA harvested from cultured rabbit aortic adventitial fibroblasts. Furthermore, the p67phox mRNA transcript in aortic fibroblasts is induced by Ang II before the peak of NADPH oxidase by Northern analysis and ribonuclease protection assays. These data suggest that Ang II stimulates NAD(P)H oxidase O2- generation in fibroblasts of aortic adventitia via transcriptional activation of p67phox. These data also provide preliminary evidence for the regulation of factors of the NADPH oxidase and potentially provide a novel means by which to abrogate the development of O2--dependent hypertension.


Key Words: rabbits • angiotensin II • superoxide • free radicals • reactive oxygen species • NADPH oxidoreductases




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
R. Siekmeier, T. Grammer, and W. Marz
Roles of Oxidants, Nitric Oxide, and Asymmetric Dimethylarginine in Endothelial Function
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2008; 13(4): 279 - 297.
[Abstract] [PDF]


Home page
HypertensionHome page
T.-D. Liao, X.-P. Yang, Y.-H. Liu, E. G. Shesely, M. A. Cavasin, W. A. Kuziel, P. J. Pagano, and O. A. Carretero
Role of Inflammation in the Development of Renal Damage and Dysfunction in Angiotensin II-Induced Hypertension
Hypertension, August 1, 2008; 52(2): 256 - 263.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. J. Haurani, M. E. Cifuentes, A. D. Shepard, and P. J. Pagano
Nox4 Oxidase Overexpression Specifically Decreases Endogenous Nox4 mRNA and Inhibits Angiotensin II-Induced Adventitial Myofibroblast Migration
Hypertension, July 1, 2008; 52(1): 143 - 149.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Yogi, C. Mercure, J. Touyz, G. E. Callera, A. C.I. Montezano, A. B. Aranha, R. C. Tostes, T. Reudelhuber, and R. M. Touyz
Renal Redox-Sensitive Signaling, but Not Blood Pressure, Is Attenuated by Nox1 Knockout in Angiotensin II-Dependent Chronic Hypertension
Hypertension, February 1, 2008; 51(2): 500 - 506.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
R. M. Wadsworth
Oxidative stress and the endothelium
Exp Physiol, January 1, 2008; 93(1): 155 - 157.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Li, X. Li, H. Zheng, B. Xie, K. R. Bidasee, and G. J. Rozanski
Pro-oxidant effect of transforming growth factor-{beta}1 mediates contractile dysfunction in rat ventricular myocytes
Cardiovasc Res, January 1, 2008; 77(1): 107 - 117.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G.-X. Zhang, X.-M. Lu, S. Kimura, and A. Nishiyama
Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation
Cardiovasc Res, November 1, 2007; 76(2): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Haurani and P. J. Pagano
Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease?
Cardiovasc Res, September 1, 2007; 75(4): 679 - 689.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. J. An, R. Boyd, M. Zhu, A. Chapman, D. R. Pimentel, and H. D. Wang
NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts
Cardiovasc Res, September 1, 2007; 75(4): 702 - 709.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev, January 1, 2007; 87(1): 245 - 313.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Johar, A. C. Cave, A. Narayanapanicker, D. J. Grieve, and A. M. Shah
Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase
FASEB J, July 1, 2006; 20(9): 1546 - 1548.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Weaver, J. Liu, D. Pimentel, D. J. Reddy, P. Harding, E. L. Peterson, and P. J. Pagano
Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1933 - H1941.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
K. R. Stenmark, N. Davie, M. Frid, E. Gerasimovskaya, and M. Das
Role of the Adventitia in Pulmonary Vascular Remodeling
Physiology, April 1, 2006; 21(2): 134 - 145.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W. J. O'Brien, C. Krema, T. Heimann, and H. Zhao
Expression of NADPH oxidase in rabbit corneal epithelial and stromal cells in culture.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 853 - 863.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
N. Ardanaz and P. J. Pagano
Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction.
Experimental Biology and Medicine, March 1, 2006; 231(3): 237 - 251.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Modlinger, T. Chabrashvili, P. S. Gill, M. Mendonca, D. G. Harrison, K. K. Griendling, M. Li, J. Raggio, A. Wellstein, Y. Chen, et al.
RNA Silencing In Vivo Reveals Role of p22phox in Rat Angiotensin Slow Pressor Response
Hypertension, February 1, 2006; 47(2): 238 - 244.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. E. Jalil, A. Perez, M. P. Ocaranza, J. Bargetto, A. Galaz, and S. Lavandero
Increased Aortic NADPH Oxidase Activity in Rats With Genetically High Angiotensin-Converting Enzyme Levels
Hypertension, December 1, 2005; 46(6): 1362 - 1367.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Somoza, M. C. Gonzalez, J. M. Gonzalez, F. Abderrahim, S. M. Arribas, and M. S. Fernandez-Alfonso
Modulatory role of the adventitia on noradrenaline and angiotensin II responses: Role of endothelium and AT2 receptors
Cardiovasc Res, February 1, 2005; 65(2): 478 - 486.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Herrera and J. L. Garvin
A high-salt diet stimulates thick ascending limb eNOS expression by raising medullary osmolality and increasing release of endothelin-1
Am J Physiol Renal Physiol, January 1, 2005; 288(1): F58 - F64.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. P. Brandes and J. Kreuzer
Vascular NADPH oxidases: molecular mechanisms of activation
Cardiovasc Res, January 1, 2005; 65(1): 16 - 27.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. T. Quinn and K. A. Gauss
Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases
J. Leukoc. Biol., October 1, 2004; 76(4): 760 - 781.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Liu, A. Ormsby, N. Oja-Tebbe, and P. J. Pagano
Gene Transfer of NAD(P)H Oxidase Inhibitor to the Vascular Adventitia Attenuates Medial Smooth Muscle Hypertrophy
Circ. Res., September 17, 2004; 95(6): 587 - 594.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Varela, M. Herrera, and J. L. Garvin
Inhibition of Na-K-ATPase in thick ascending limbs by NO depends on O2- and is diminished by a high-salt diet
Am J Physiol Renal Physiol, August 1, 2004; 287(2): F224 - F230.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Q. Liu and R. J. Folz
Extracellular superoxide enhances 5-HT-induced murine pulmonary artery vasoconstriction
Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L111 - L118.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. A. Jaimes, E. G. DeMaster, R.-X. Tian, and L. Raij
Stable Compounds of Cigarette Smoke Induce Endothelial Superoxide Anion Production via NADPH Oxidase Activation
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1031 - 1036.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. J. Ryan, S. P. Didion, S. Mathur, F. M. Faraci, and C. D. Sigmund
Angiotensin II-Induced Vascular Dysfunction Is Mediated by the AT1A Receptor in Mice
Hypertension, May 1, 2004; 43(5): 1074 - 1079.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Z. Haque and D. S. A. Majid
Assessment of Renal Functional Phenotype in Mice Lacking gp91PHOX Subunit of NAD(P)H Oxidase
Hypertension, February 1, 2004; 43(2): 335 - 340.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Lopez, M. G. Salom, B. Arregui, F. Valero, and F. J. Fenoy
Role of Superoxide in Modulating the Renal Effects of Angiotensin II
Hypertension, December 1, 2003; 42(6): 1150 - 1156.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Kitiyakara, T. Chabrashvili, Y. Chen, J. Blau, A. Karber, S. Aslam, W. J. Welch, and C. S. Wilcox
Salt Intake, Oxidative Stress, and Renal Expression of NADPH Oxidase and Superoxide Dismutase
J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2775 - 2782.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M.-S. Zhou, A. G. Adam, E. A. Jaimes, and L. Raij
In Salt-Sensitive Hypertension, Increased Superoxide Production Is Linked to Functional Upregulation of Angiotensin II
Hypertension, November 1, 2003; 42(5): 945 - 951.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Higashi, H. Shimokawa, T. Hattori, J. Hiroki, Y. Mukai, K. Morikawa, T. Ichiki, S. Takahashi, and A. Takeshita
Long-Term Inhibition of Rho-Kinase Suppresses Angiotensin II-Induced Cardiovascular Hypertrophy in Rats In Vivo: Effect on Endothelial NAD(P)H Oxidase System
Circ. Res., October 17, 2003; 93(8): 767 - 775.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Lassegue and R. E. Clempus
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R277 - R297.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Chabrashvili, C. Kitiyakara, J. Blau, A. Karber, S. Aslam, W. J. Welch, and C. S. Wilcox
Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R117 - R124.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R.M. Touyz, G. Yao, and E.L. Schiffrin
c-Src Induces Phosphorylation and Translocation of p47phox: Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 981 - 987.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Liu, F. Yang, X.-P. Yang, M. Jankowski, and P. J. Pagano
NAD(P)H Oxidase Mediates Angiotensin II-Induced Vascular Macrophage Infiltration and Medial Hypertrophy
Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 776 - 782.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. M. Jacobson, H. M. Dourron, J. Liu, O. A. Carretero, D. J. Reddy, T. Andrzejewski, and P. J. Pagano
Novel NAD(P)H Oxidase Inhibitor Suppresses Angioplasty-Induced Superoxide and Neointimal Hyperplasia of Rat Carotid Artery
Circ. Res., April 4, 2003; 92(6): 637 - 643.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
I. V. Turko and F. Murad
Protein Nitration in Cardiovascular Diseases
Pharmacol. Rev., December 1, 2002; 54(4): 619 - 634.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. E. Rey and P. J. Pagano
The Reactive Adventitia: Fibroblast Oxidase in Vascular Function
Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 1962 - 1971.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Tojo, M. L. Onozato, N. Kobayashi, A. Goto, H. Matsuoka, and T. Fujita
Angiotensin II and Oxidative Stress in Dahl Salt-Sensitive Rat With Heart Failure
Hypertension, December 1, 2002; 40(6): 834 - 839.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. E. Kim, Y. S. Suh, M.-S. Lee, K. Y. Kim, J. H. Lee, H. S. Lee, K. W. Hong, and C. D. Kim
Vascular NAD(P)H Oxidase Triggers Delayed Cerebral Vasospasm After Subarachnoid Hemorrhage in Rats
Stroke, November 1, 2002; 33(11): 2687 - 2691.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
U. Rueckschloss, M. T. Quinn, J. Holtz, and H. Morawietz
Dose-Dependent Regulation of NAD(P)H Oxidase Expression by Angiotensin II in Human Endothelial Cells: Protective Effect of Angiotensin II Type 1 Receptor Blockade in Patients With Coronary Artery Disease
Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1845 - 1851.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
L Van Heerebeek, C Meischl, W Stooker, C J L M Meijer, H W M Niessen, and D Roos
NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?
J. Clin. Pathol., August 1, 2002; 55(8): 561 - 568.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. M. Touyz, X. Chen, F. Tabet, G. Yao, G. He, M. T. Quinn, P. J. Pagano, and E. L. Schiffrin
Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II
Circ. Res., June 14, 2002; 90(11): 1205 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Mollnau, M. Wendt, K. Szocs, B. Lassegue, E. Schulz, M. Oelze, H. Li, M. Bodenschatz, M. August, A. L. Kleschyov, et al.
Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling
Circ. Res., March 8, 2002; 90 (4): e58 - e65.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Shihabi, W.-G. Li, F. J. Miller Jr., and N. L. Weintraub
Antioxidant therapy for atherosclerotic vascular disease: the promise and the pitfalls
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H797 - H802.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. A. Gauss, P. L. Mascolo, D. W. Siemsen, L. K. Nelson, P. L. Bunger, P. J. Pagano, and M. T. Quinn
Cloning and sequencing of rabbit leukocyte NADPH oxidase genes reveals a unique p67phox homolog
J. Leukoc. Biol., February 1, 2002; 71(2): 319 - 328.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. K. Kim, M.-S. Lee, S. M. Son, I. J. Kim, W. S. Lee, B. Y. Rhim, K. W. Hong, and C. D. Kim
Vascular NADH Oxidase Is Involved in Impaired Endothelium-Dependent Vasodilation in OLETF Rats, a Model of Type 2 Diabetes
Diabetes, February 1, 2002; 51(2): 522 - 527.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Ren, O. A. Carretero, and J. L. Garvin
Mechanism by Which Superoxide Potentiates Tubuloglomerular Feedback
Hypertension, February 1, 2002; 39(2): 624 - 628.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. K. Bendall, A. C. Cave, C. Heymes, N. Gall, and A. M. Shah
Pivotal Role of a gp91phox-Containing NADPH Oxidase in Angiotensin II-Induced Cardiac Hypertrophy in Mice
Circulation, January 22, 2002; 105(3): 293 - 296.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Berry, R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2337 - H2365.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Irani
Angiotensin II-Stimulated Vascular Remodeling : The Search for the Culprit Oxidase
Circ. Res., May 11, 2001; 88(9): 858 - 860.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. J. Miller Jr
Adventitial Fibroblasts : Backstage Journeymen
Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 722 - 723.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Shi, R. Niculescu, D. Wang, S. Patel, K. L. Davenpeck, and A. Zalewski
Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury
Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 739 - 745.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. E. J. West, T. J. Guzik, E. Black, and K. M. Channon
Enhanced Superoxide Production in Experimental Venous Bypass Graft Intimal Hyperplasia : Role of NAD(P)H Oxidase
Arterioscler Thromb Vasc Biol, February 1, 2001; 21(2): 189 - 194.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Raij
Workshop: Hypertension and Cardiovascular Risk Factors : Role of the Angiotensin II-Nitric Oxide Interaction
Hypertension, February 1, 2001; 37(2): 767 - 773.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Nishiyama, T. Fukui, Y. Fujisawa, M. Rahman, R.-X. Tian, S. Kimura, and Y. Abe
Systemic and Regional Hemodynamic Responses to Tempol in Angiotensin II-Infused Hypertensive Rats
Hypertension, January 1, 2001; 37(1): 77 - 83.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. M. Touyz and E. L. Schiffrin
Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells
Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. E. Cifuentes, F. E. Rey, O. A. Carretero, and P. J. Pagano
Upregulation of p67phox and gp91phox in aortas from angiotensin II-infused mice
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2234 - H2240.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Leopold and J. Loscalzo
Cyclic strain modulates resistance to oxidant stress by increasing G6PDH expression in smooth muscle cells
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2477 - H2485.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. K. Griendling, D. Sorescu, B. Lassegue, and M. Ushio-Fukai
Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology
Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2175 - 2183.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. GÖRLACH, R. P. BRANDES, S. BASSUS, N. KRONEMANN, C. M. KIRCHMAIER, R. BUSSE, and V. B. SCHINI-KERTH
Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets
FASEB J, August 1, 2000; 14(11): 1518 - 1528.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
P. J. Pagano
Vascular gp91phox : Beyond the Endothelium
Circ. Res., July 7, 2000; 87(1): 1 - 3.
[Full Text] [PDF]


Home page
CirculationHome page
C. Berry, C. A. Hamilton, M. J. Brosnan, F. G. Magill, G. A. Berg, J. J. V. McMurray, and A. F. Dominiczak
Investigation Into the Sources of Superoxide in Human Blood Vessels : Angiotensin II Increases Superoxide Production in Human Internal Mammary Arteries
Circulation, May 9, 2000; 101(18): 2206 - 2212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. J. Welch, A. Tojo, and C. S. Wilcox
Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR
Am J Physiol Renal Physiol, May 1, 2000; 278(5): F769 - F776.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Hsich, B. H. Segal, P. J. Pagano, F. E. Rey, B. Paigen, J. Deleonardis, R. F. Hoyt, S. M. Holland, and T. Finkel
Vascular Effects Following Homozygous Disruption of p47phox : An Essential Component of NADPH Oxidase
Circulation, March 21, 2000; 101(11): 1234 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. K. Griendling, D. Sorescu, and M. Ushio-Fukai
NAD(P)H Oxidase : Role in Cardiovascular Biology and Disease
Circ. Res., March 17, 2000; 86(5): 494 - 501.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. K. WATTANAPITAYAKUL, D. M. WEINSTEIN, B. J. HOLYCROSS, and J. A. BAUER
Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders
FASEB J, February 1, 2000; 14(2): 271 - 278.
[Abstract] [Full Text]


Home page
CirculationHome page
G. Li, Y.-F. Chen, G. L. Greene, S. Oparil, and J. A. Thompson
Estrogen Inhibits Vascular Smooth Muscle Cell-Dependent Adventitial Fibroblast Migration In Vitro
Circulation, October 12, 1999; 100(15): 1639 - 1645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-Y. Sohn, M. Keller, T. Gloe, H. Morawietz, U. Rueckschloss, and U. Pohl
The Small G-protein Rac Mediates Depolarization-induced Superoxide Formation in Human Endothelial Cells
J. Biol. Chem., June 16, 2000; 275(25): 18745 - 18750.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Xiao, D. R. Pimentel, J. Wang, K. Singh, W. S. Colucci, and D. B. Sawyer
Role of reactive oxygen species and NAD(P)H oxidase in alpha 1-adrenoceptor signaling in adult rat cardiac myocytes
Am J Physiol Cell Physiol, April 1, 2002; 282(4): C926 - C934.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. D. Wang, D. G. Johns, S. Xu, and R. A. Cohen
Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II
Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1697 - H1702.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. D. Wang, S. Xu, D. G. Johns, Y. Du, M. T. Quinn, A. J. Cayatte, and R. A. Cohen
Role of NADPH Oxidase in the Vascular Hypertrophic and Oxidative Stress Response to Angiotensin II in Mice
Circ. Res., May 9, 2001; 88(9): 947 - 953.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. Lassegue, D. Sorescu, K. Szocs, Q. Yin, M. Akers, Y. Zhang, S. L. Grant, J. D. Lambeth, and K. K. Griendling
Novel gp91phox Homologues in Vascular Smooth Muscle Cells : nox1 Mediates Angiotensin II-Induced Superoxide Formation and Redox-Sensitive Signaling Pathways
Circ. Res., May 11, 2001; 88(9): 888 - 894.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. E. Rey, M. E. Cifuentes, A. Kiarash, M. T. Quinn, and P. J. Pagano
Novel Competitive Inhibitor of NAD(P)H Oxidase Assembly Attenuates Vascular O2- and Systolic Blood Pressure in Mice
Circ. Res., August 31, 2001; 89(5): 408 - 414.
[Abstract] [Full Text] [PDF]